Risk Factors and Clinical Significance of Lower Perigastric Lymph Node Metastases in Siewert Type II and III Esophagogastric Junction Adenocarcinoma: a Retrospective Cohort Study

Xinyu Qi,Maoxing Liu,Kai Xu,Fei Tan,Pin Gao,Zhendan Yao,Nan Zhang,Hong Yang,Chenghai Zhang,Jiadi Xing,Ming Cui,Xiangqian Su
DOI: https://doi.org/10.1007/s00464-024-10875-y
2024-01-01
Surgical Endoscopy
Abstract:No consensus has been concluded with regarding to the scope of lymph node (LN) dissection for Siewert type II and III adenocarcinoma of the esophagogastric junction (AEG). This study aimed to explore risk factors for lower perigastric LN (LPLN) metastases (including no. 4d, 5, 6, and 12a LN stations) and analyze the indications for LPLN dissection. In total, 302 consecutive patients with Siewert type II and III AEG who underwent total gastrectomy (TG) were enrolled. The logistic regression model was used to perform uni- and multivariate analyses of risk factors for LPLN metastases. Kaplan–Meier curves were used for survival analysis, and log-rank tests were used for group comparisons. Basing on the guidelines of Japanese Gastric Cancer Association, the LN metastases (LNM) as well as the efficiency index (EI) of each LN station was further evaluated. The independent risk factors for LPLN metastases in patients with Siewert type II and III AEG were distance from the esophagogastric junction (EGJ) to the distal end of the tumor (> 4.0 cm), preoperative carcinoembryonic antigen (CEA) ( +), pT4 stage, and HER-2 ( +). LPLN metastases was an independent risk factor for overall survival following TG. The LNM and EI of LPLN were 8.6
What problem does this paper attempt to address?